Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

DNA methylation changes in gastrointestinal disease.

Minoru Toyota1, Fumio Itoh, Takefumi Kikuchi

  • 1First Department of Internal Medicine, Cancer Research Institute, Sapporo Medical University, S-1, W-16, Chuo-ku, Sapporo 060-8543, Japan.

Journal of Gastroenterology
|February 8, 2003
PubMed
Summary

Aberrant DNA methylation in the colon is linked to gastrointestinal cancers and inflammatory bowel disease. This epigenetic change may serve as an early diagnostic marker for these conditions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Feasibility of Zeosuture M for gastric endoscopic submucosal dissection defect closure during anticoagulation: a preclinical porcine study from Japan.

Clinical endoscopy·2026
Same author

Association Between Pain-Related Kinesiophobia and Sedentary Behavior in Older Patients With Lumbar Spine Disease.

The Clinical journal of pain·2026
Same author

Recurrent Mutations in Protein Tyrosine Phosphatase Receptor Type Kappa (PTPRK) in Depressed-Type Colorectal Carcinomas.

Journal of biochemistry·2026
Same author

Lipopeptide ligands captured by MHC class I molecules undergo dynamic conformational changes that affect their antigenic strength.

The Journal of biological chemistry·2025
Same author

Pan-Cancer Analysis Reveals AEBP1-Collagen Co-Expression and Its Potential Role in CAF-Mediated Tumor Stiffness.

International journal of molecular sciences·2025
Same author

DOT1L inhibition exerts the anti-tumor effect by activating interferon signaling in breast cancer cells.

Clinical epigenetics·2025

Area of Science:

  • Epigenetics
  • Molecular Biology
  • Oncology

Background:

  • DNA methylation, particularly in gene 5' regions, is a known mechanism for gene silencing.
  • Aberrant DNA methylation is implicated in the inactivation of tumor suppressor genes (e.g., p16INK4A) and DNA repair genes (e.g., hMLH1).
  • Colorectal adenomas and even normal-appearing colon epithelium in aging individuals exhibit significant DNA methylation, suggesting its early role in tumorigenesis.

Purpose of the Study:

  • To investigate the role of DNA methylation in gastrointestinal cancers and inflammatory bowel disease.
  • To explore the potential of DNA methylation as a diagnostic marker for these conditions.

Main Methods:

  • Analysis of DNA methylation patterns in colon tissue samples.
  • Comparison of methylation levels in normal colon epithelium, adenomas, and mucosa from patients with inflammatory bowel disease.

Related Experiment Videos

Main Results:

  • Colorectal adenomas demonstrate a high frequency of aberrant DNA methylation.
  • Significant DNA methylation was observed in a subset of genes in normal-appearing colon epithelium from aging patients.
  • Colon mucosa from patients with inflammatory bowel disease also exhibited elevated DNA methylation levels.

Conclusions:

  • Aberrant DNA methylation is an early event in colorectal tumorigenesis.
  • DNA methylation patterns may serve as a valuable diagnostic marker for gastrointestinal cancer and inflammatory bowel disease.
  • Further research is needed to develop noninvasive diagnostic methods based on DNA methylation.